Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TBXAS1 | P24557 | 3/20 | 0.37 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | AHR | P35869 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.31 |
| ▸ | NAMPT | P43490 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17337339 | 0.92 | TBXAS1 (0.39) | TBXAS1ROCK2ALDH1A1KDM4EAHR | |
| SCHEMBL17337337 | 0.92 | TBXAS1 (0.39) | TBXAS1ROCK2ALDH1A1KDM4EAHR | |
| SCHEMBL23837531 | 0.91 | TBXAS1 (0.36) | TBXAS1ROCK2ALDH1A1KDM4EAHR | |
| SCHEMBL23837398 | 0.91 | ROCK2 (0.38) | TBXAS1ROCK2ALDH1A1KDM4EAHR | |
| SCHEMBL17337442 | 0.90 | TBXAS1 (0.40) | TBXAS1ROCK2ALDH1A1KDM4EMEN1 | |
| SCHEMBL17337446 | 0.90 | TBXAS1 (0.40) | TBXAS1ROCK2ALDH1A1KDM4EMEN1 | |
| SCHEMBL17337153 | 0.89 | TBXAS1 (0.46) | TBXAS1ROCK2ALDH1A1KDM4EAHR | |
| SCHEMBL17337151 | 0.89 | TBXAS1 (0.46) | TBXAS1ROCK2ALDH1A1KDM4EAHR | |
| SCHEMBL17347848 | 0.88 | KDM4E (0.43) | TBXAS1ROCK2ALDH1A1KDM4EAHR | |
| SCHEMBL18072140 | 0.88 | TBXAS1 (0.37) | TBXAS1ROCK2ALDH1A1KDM4EAHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3882252-A1 | BETA-LACTAMASE INHIBITORS | Venatorx Pharmaceuticals, Inc. (US) | 2021-09-22 | — | — | EP | disclosed |